News Shire buys rights to Pfizer gastrointestinal drug Shire has bought rights to PF-00547659 for an undisclosed sum.
Articles A history of Shire The history of one of the world's biggest speciality and rare disease pharmaceutical companies
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.